Miyamoto Yoshiaki, Iida Asako, Sato Keiji, Muramatsu Shin-ichi, Nitta Atsumi
Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan (Drs Miyamoto, Sato, and Nitta); Division of Neurology, Department of Medicine, Jichi Medical University, Tochigi, Japan (Drs Iida and Muramatsu).
Int J Neuropsychopharmacol. 2014 Oct 31;18(4):pyu038. doi: 10.1093/ijnp/pyu038.
Addictive drugs lead to reinforcing properties by increasing dopamine in the nucleus accumbens, which is composed of a core and shell regions. Neurons in the nucleus accumbens are divided into 2 subtypes based on the differential gene expression of the dopamine D₁ receptors and D₂ receptors.
In the present study, we investigated the role of D₂ receptors in the nucleus accumbens core in behaviors and signal transduction induced by psychostimulant methamphetamine in mice that were microinjected with adeno-associated virus vectors containing a microRNA (miRNA) sequence for D₂ receptor (adeno-associated virus-miD2r vectors) in the nucleus accumbens core. The adeno-associated virus vectors containing a miRNA sequence for D₂ receptor-treated mice (miD₂r mice) were assessed at a reduction in D₂ receptor, but at no change in dopamine D₁ receptor, in the nucleus accumbens core compared with the adeno-associated virus-Mock vectors-treated mice (Mock mice).
miD₂r mice exhibited a reduction in hyperlocomotion that was induced by a single treatment with methamphetamine. The development of locomotor sensitization induced by repeated treatment with methamphetamine exhibited less extension in miD₂r mice. In a place conditioning paradigm, the preferred effects of methamphetamine were significantly weaker in miD₂r mice than in Mock mice. Furthermore, the single treatment with methamphetamine-induced phosphorylation of extracellular signal regulated kinase and cyclic adenosine monophosphate response element-binding protein in the nucleus accumbens core of miD₂r mice was decreased compared with that in Mock mice. Repeated treatment with methamphetamine-induced delta FBJ murine osteosarcoma viral oncogene homolog B accumulation in the nucleus accumbens core of miD₂r mice was also attenuated.
These findings suggest that a D₂ receptor-mediated neuronal pathway from the nucleus accumbens core plays an inhibitory role in the development of reinforcing properties.
成瘾性药物通过增加伏隔核中的多巴胺来产生强化作用,伏隔核由核心区和壳区组成。伏隔核中的神经元根据多巴胺D₁受体和D₂受体的差异基因表达分为两种亚型。
在本研究中,我们研究了伏隔核核心区D₂受体在精神兴奋剂甲基苯丙胺诱导的小鼠行为和信号转导中的作用。将含有D₂受体微小RNA(miRNA)序列的腺相关病毒载体微注射到伏隔核核心区的小鼠,评估其对甲基苯丙胺诱导行为的影响。与腺相关病毒空载体处理的小鼠(Mock小鼠)相比,含D₂受体miRNA序列处理的小鼠(miD₂r小鼠)伏隔核核心区D₂受体减少,但多巴胺D₁受体无变化。
miD₂r小鼠单次注射甲基苯丙胺诱导的运动亢进减少。甲基苯丙胺重复注射诱导的运动敏化在miD₂r小鼠中的发展程度较低。在条件性位置偏爱范式中,miD₂r小鼠中甲基苯丙胺的偏爱效应明显弱于Mock小鼠。此外,与Mock小鼠相比,miD₂r小鼠伏隔核核心区单次注射甲基苯丙胺诱导的细胞外信号调节激酶和环磷酸腺苷反应元件结合蛋白的磷酸化减少。甲基苯丙胺重复注射诱导的miD₂r小鼠伏隔核核心区δFBJ小鼠骨肉瘤病毒癌基因同源物B的积累也减弱。
这些发现表明,伏隔核核心区由D₂受体介导的神经元通路在强化特性的发展中起抑制作用。